A new prenylated indole derivative from endophytic actinobacteria Streptomyces sp. neau-D50.
Ji Zhang,Ji-Dong Wang,Chong-Xi Liu,Jia-Hui Yuan,Xiang-Jing Wang,Wen-Sheng Xiang
DOI: https://doi.org/10.1080/14786419.2013.871546
2014-01-01
Natural Product Research
Abstract:A new prenylated indole derivative 3-acetonylidene-7-prenylindolin-2-one (1) was isolated from the endophytic actinobacterium Streptomyces sp. neau-D50, together with four known hybrid isoprenoids, 7-isoprenylindole-3-carboxylic acid (2), 3-cyanomethyl-6-prenylindole (3), 6-isoprenylindole-3-carboxylic acid (4) and 7,4 '-dihydroxy-5-methoxy-8-(gamma,gamma-dimethylallyl)-flavanone (5). The structures of these compounds were elucidated on the basis of extensive spectroscopic analysis and comparison with data from the literature. Compounds 1 and 2 demonstrated strong cytotoxic activities against human lung adenocarcinoma cell line A549 with an IC50 of 3.3 and 5.1 mu gmL(-1), respectively, which are comparable to that of the positive control doxorubicin (4.2 mu gmL(-1)). Furthermore, compounds 1-4 exhibited potent antifungal activity against phytopathogenic fungi Colletotrichum orbiculare, Phytophthora capsici, Corynespora cassiicola and Fusarium oxysporum.
What problem does this paper attempt to address?